论文部分内容阅读
目的:探究前列地尔注射液用于缺血性脑血管病的临床价值。方法:选取2010年1月-2015年1月本院300例缺血性脑血管病患者作为研究对象,并随机的分为两组,每组150例,观察组采用前列地尔注射液进行治疗,对照组采用灯盏细辛注射液进行治疗,观察比较两组患者疗效。结果:经过治疗后,观察组患者的神经功能缺损评分的改善幅度和总有效率明显优于对照组,差异具有统计学意义(P<0.05);两组患者均出现脸红与轻度恶心的症状,但对治疗无影响,无恶化与死亡病例。结论:前列地尔注射液对缺血性脑血管病的治疗效果显著,能够促使患者的神经功能缺损情况得到有效的改善,促使患者的生活能力不断提高。
Objective: To investigate the clinical value of alprostadil injection for ischemic cerebrovascular disease. Methods: A total of 300 patients with ischemic cerebrovascular disease in our hospital from January 2010 to January 2015 were selected and randomly divided into two groups (n = 150 each). The observation group was treated with alprostadil , The control group was treated with Erigeron Breviscapus Injection, and the curative effect was observed and compared between the two groups. Results: After treatment, the improvement rate and total effective rate of the neurological deficit score in the observation group were significantly better than those in the control group (P <0.05); both patients had blush and mild nausea symptoms , But no effect on treatment, no deterioration and deaths. Conclusion: Alprostadil injection has a significant therapeutic effect on ischemic cerebrovascular disease, which can effectively improve the patients ’neurological deficits and promote the patients’ living ability.